Germline mutations in BRCA2: Shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia

Blood

Volumn 103, Issue 8, 2004, Pages 3226-3229

  Wagner, John E ^a   Tolar, Jakub ^b   Levran, Orna ^b   Scholl, Thomas ^b   Deffenbaugh, Amie ^b   Satagopan, Jaya ^b   Ben Porat, Leah ^b   Mah, Katherine ^b   Batish, Sat Dev ^b   Kutler, David I ^b   MacMillan, Margaret L ^b   Hanenberg, Helmut ^b   Auerbach, Arleen D ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; GENE PRODUCT; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW TRANSPLANTATION; BREAST CARCINOMA; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHILD; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FANCONI ANEMIA; GENE IDENTIFICATION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; LEUKEMIA; ONSET AGE; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 11144353924     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-09-3138     Document Type: Article

References (20)

1. Kuller DI, Singh B, Satagopan J, et al. A 20 year perspective of The International Fanconi Anemia Registry (IFAR). Blood. 2003;101:1249-1256.
2. Bagby GC Jr. Genetic basis of Fanconi anemia. Curr Opin Hematol. 2003;10:68-76.
3. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer. 2003;3:23-34.
4. Meetei AR, de Winter JP, Medhurst AL, et al. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol 2003;23:3417-3426.
5. Meetei AR, de Winter JP, Medhurst AL, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet. 2003;35:165-170.
6. Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 2002;297:606-609.
7. Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood. 1989;73:391-396.
8. Verlander PC, Kaporis AG, Liu Q, et al. Carrier frequency of the IVS4+4A>T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood. 1995;86:4034-4038.
9. Levan O, Erlich T, Magdalena N, et al. Sequence variation in the Fanconi anemia gene FAA. Proc Natl Acad Sci U S A. 1997;94:13051-13056.
10. Auerbach AD, Pujara K, Greenbaum J, et al. Spectrum of sequence variation in the FANCG gene: an International Fanconi Anemia Registry (IFAR) study. Hum Mutat. 2003;21:158-168.
11. Hanenberg H, Batish SD, Pollok KE, et al. Phenotypic correction of primary T cells from patients with Fanconi anemia with retrovinal vectors as a diagnostic tool. Exp Hematol. 2002;30:410-420.
12. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
13. Pyne MT, Brothman AR, Ward B, et al. The BRCA2 genetic variant IVS7+2T>G is a mutation. J Hum Genet. 2000;45:351-357.
14. National Human Genome Research Institute. Open Access On-Line Breast Cancer Mutation Data Base [database online]. Available at: http://www.nhgri.nih.gov/Intramural_research/Lab_transfer/Bic/. Accessed July 2003.
15. Healey CS, Dunning AM, Teare MD, et al. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet. 2000;26:362-364.
16. Ikeda H, Matsushita M, Waisfisz Q, et al. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2. Cancer Res. 2003;63:2688-2694.
17. Offit K, Levran O, Mullaney B, et al. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi Anemia. J. Natl Cancer Inst. 2003;95:1548-1551.
18. Auerbach AD, Levran O, Mullaney B, et al. Unique phenotype associated with biallelic BRCA2 mutations includes high risk of brain tumors, Wilms tumors and early onset acute leukemia in children with Fanconi anemia [abstract]. Am J Hum Genet. 2003;73:173.
19. Wagner JE, MacMillan M, Auerbach AD. Hematopoietic cell transplantation for Fanconi anemia. In: Blume KG, Forman, SJ, Appelbaum FR, eds. Thomas' Hematopoietic Cell Transplantation. Oxford, United Kingdom: Blackwell Science Ltd; 2004:1483-1506.
20. Kauff ND, Satagopan JM, Scheuer L, et al. Risk-reducing salpingo-oophorectomy in women with BRCA1 and BRCA2 mutations. N Engl J Med. 2002;246:1609-1615.